ArticleScientific reports2023

Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients.

Wenjie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.